DrugPatentWatch Database Preview
Etomidate - Generic Drug Details
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What are the generic drug sources for etomidate and what is the scope of freedom to operate?
Etomidate
is the generic ingredient in two branded drugs marketed by Hospira, Aurobindo Pharma Ltd, Emcure Pharms Ltd, Gland Pharma Ltd, Hikma, Luitpold, Mylan Labs Ltd, Par Sterile Products, West-ward Pharms Int, and Zydus Pharms, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.There are six drug master file entries for etomidate. Twelve suppliers are listed for this compound.
Summary for etomidate
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 10 |
| NDAs: | 11 |
| Drug Master File Entries: | 6 |
| Suppliers / Packagers: | 12 |
| Bulk Api Vendors: | 132 |
| Clinical Trials: | 64 |
| Patent Applications: | 4,335 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | etomidate at DailyMed |
Recent Clinical Trials for etomidate
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Ajou University School of Medicine | N/A |
| Unimedics (http://unimedics.co.kr) | N/A |
| Samuel Lunenfeld Research Institute, Mount Sinai Hospital | N/A |
Pharmacology for etomidate
| Drug Class | General Anesthetic |
| Physiological Effect | General Anesthesia |
Medical Subject Heading (MeSH) Categories for etomidate
Synonyms for etomidate
| (-)-ethyl 1-(1-phenylethyl)-1H-imidazole- 5-carboxylate |
| (-)-ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate |
| (?)-Etomidate |
| (+)-Ethyl 1-(.alpha.-methylbenzyl)imidazole-5-carboxylate |
| (+)-Ethyl 1-(alpha-methylbenzyl)imidazole-5-carboxylate |
| (+)-Etomidate |
| (d)-Etomidate |
| (R)-(+)-1-(.alpha.-Methylbenzyl)imidazole-5-carboxylic acid ethyl ester |
| (R)-(+)-1-(1-Phenylethyl)-1H-imidazole-5-carboxylic Acid Ethyl Ester |
| (R)-(+)-1-(alpha-Methylbenzyl)imidazole-5-carboxylic acid ethyl ester |
| (R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester |
| (R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylicacid ethyl ester |
| (R)-ETHYL 1-(1-PHENYLETHYL)-1H-IMIDAZOLE-5-CARBOXYLATE |
| [R,(+)]-1-(alpha-Methylbenzyl)-1H-imidazole-5-carboxylic acid ethyl ester |
| 1-(.alpha.-Methylbenzyl)-1H-imidazole-5-carboxylic acid ethyl ester |
| 1-(1-Phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester |
| 1-(1-Phenylethyl)-imidazole-5-carboxylic acid, ethyl ester |
| 1-(alpha-Methylbenzyl)-1H-imidazole-5-carboxylic acid ethyl ester |
| 125E972 |
| 15301-65-2 |
| 1H-Imidazole-5-carboxylic acid, 1-(.alpha.-methylbenzyl)-, ethyl ester, (+)- |
| 1H-Imidazole-5-carboxylic acid, 1-((1R)-1-phenylethyl)-, ethyl ester |
| 1H-Imidazole-5-carboxylic acid, 1-(1-phenylethyl)-, ethyl ester, (+-)- |
| 1H-Imidazole-5-carboxylic acid, 1-(1-phenylethyl)-, ethyl ester, (+)- |
| 1H-Imidazole-5-carboxylic acid, 1-(1-phenylethyl)-, ethyl ester, (R)- |
| 1H-Imidazole-5-carboxylic acid, 1-(1-phenylethyl)-, ethyl ester, (R)- [CAS] |
| 1H-Imidazole-5-carboxylic acid, 1-[(1R)-1-phenylethyl]-, ethyl ester |
| 1H-Imidazole-5-carboxylic acid, 1-[(1S)-1-phenylethyl]-, ethyl ester |
| 2403AH |
| 3-((R)-1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester |
| 3-((S)-1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester |
| 3-(1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester |
| 3-[(1R)-1-phenylethyl]-4-imidazolecarboxylic acid ethyl ester |
| 33125-97-2 |
| 4CH-007314 |
| 56649-47-9 |
| A821630 |
| AB0012165 |
| AB00439988_13 |
| AB00439988-11 |
| AB00514014 |
| AB00639951_06 |
| AB2000049 |
| Absele |
| AC-5898 |
| AC1L1VLF |
| AC1LDI6L |
| AC1O3UGO |
| AC1Q34BV |
| AC1Q64LP |
| AJ-08018 |
| AK-49072 |
| AKOS000548952 |
| AKOS015920052 |
| AKOS021628930 |
| AKOS030240711 |
| AM803710 |
| Amidate |
| Amidate (pharmaceutical) |
| Amidate (TN) |
| AN-379 |
| AX8129871 |
| BAS 01947657 |
| BC203897 |
| BCP21365 |
| BDBM238149 |
| BDBM50125935 |
| BDBM50125937 |
| BG0367 |
| BPBio1_001060 |
| BR-49072 |
| BRD-A54880345-001-11-8 |
| BRD-K55055802-001-10-2 |
| BRN 0665833 |
| BSPBio_000962 |
| C07522 |
| C14H16N2O2 |
| CAS-33125-97-2 |
| CCG-101054 |
| CCG-221041 |
| CHEBI:4910 |
| CHEBI:91759 |
| CHEBI:95268 |
| CHEMBL23731 |
| CHEMBL279678 |
| CHEMBL681 |
| CPD000010931 |
| CPD000466277 |
| CS-1833 |
| CTK1F4139 |
| CTK6F7213 |
| D-Etomidate |
| D00548 |
| DB00292 |
| DS-14867 |
| DSSTox_CID_3033 |
| DSSTox_GSID_23033 |
| DSSTox_RID_76841 |
| DTXSID5023033 |
| E-200 |
| E0897 |
| EINECS 251-385-9 |
| EN300-50290 |
| Ethnor |
| Ethomidate |
| Ethyl (R)-(+)-1-(1-Phenylethyl)-1H-imidazole-5-carboxylate |
| ethyl (R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylate |
| Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate |
| Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate, (+)- |
| ethyl 1-(phenylethyl)imidazole-5-carboxylate |
| ethyl 1-[(1R)-1-phenylethyl]-1H-imidazole-5-carboxylate |
| ethyl 3-(1-phenylethyl)imidazole-4-carboxylate |
| Ethyl 3-(1-phenylethyl)imidazole-4-carboxylate. |
| ethyl 3-[(1R)-1-phenylethyl]imidazole-4-carboxylate |
| ethyl 3-[(1S)-1-phenylethyl]imidazole-4-carboxylate |
| Etomidate (USAN/INN) |
| Etomidate [USAN:BAN:INN] |
| Etomidate [USAN:USP:INN:BAN] |
| Etomidate 0.1 mg/ml in Methanol |
| Etomidate 1.0 mg/ml in Methanol |
| Etomidate, >98% (HPLC), powder |
| Etomidate, European Pharmacopoeia (EP) Reference Standard |
| Etomidate, United States Pharmacopeia (USP) Reference Standard |
| Etomidato |
| Etomidato [INN-Spanish] |
| Etomidatum |
| Etomidatum [INN-Latin] |
| Etomidic acid |
| FT-0630568 |
| GS-3208 |
| GTPL5463 |
| HMS1571A04 |
| HMS1612G10 |
| HMS2051P18 |
| HMS2093P17 |
| HMS2098A04 |
| HMS2232A08 |
| HMS2234K12 |
| HMS2235K14 |
| HMS3259F15 |
| HMS3267N06 |
| HMS3369P19 |
| HMS3371K15 |
| HMS3393P18 |
| HMS3428L14 |
| HMS3654N15 |
| HMS3715A04 |
| HY-B0100 |
| Hypnomidate |
| Imidazole-5-carboxylic acid, 1-(.alpha.-methylbenzyl)-, ethyl ester, (R)-(+)- |
| Imidazole-5-carboxylic acid, 1-(alpha-methylbenzyl)-, ethyl ester, (R)-(+)- |
| J10465 |
| KB-51833 |
| KS-00000G8T |
| Lipuro |
| LS-78232 |
| MCULE-8274432743 |
| MFCD00869295 |
| MLS000034952 |
| MLS000758268 |
| MLS001240191 |
| MLS001424163 |
| MLS002154118 |
| MLS006011948 |
| MolPort-000-917-569 |
| MolPort-003-983-475 |
| NC00304 |
| NC00657 |
| NCGC00016817-01 |
| NCGC00016817-02 |
| NCGC00025176-01 |
| NCGC00025176-02 |
| NCGC00036076-03 |
| NE51441 |
| NPUKDXXFDDZOKR-UHFFFAOYSA-N |
| NSC-759160 |
| NSC759160 |
| Opera_ID_1830 |
| Pharmakon1600-01505599 |
| Prestwick0_001041 |
| Prestwick1_001041 |
| Prestwick2_001041 |
| Prestwick3_001041 |
| PubChem6027 |
| Q-201102 |
| R 16659 |
| R-(+) ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate |
| R-(+)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate |
| r-(+)-ethyl-1-(1-phenylethyl)-1h-imidazole-5-carboxylate |
| R-(+)-etomidate |
| R-16659 |
| R-26490 |
| R-ETOMIDATE |
| R(+)-etomidate |
| R16659 |
| Radenarcon |
| Radenarkon |
| RL03203 |
| S-(-)-Etomidate |
| S-3872 |
| S-ETOMIDATE |
| S(-)-Etomidate |
| s1329 |
| SAM001247074 |
| SAM002548930 |
| SBB066197 |
| SBI-0206822.P001 |
| SC-03534 |
| SCHEMBL39485 |
| SCHEMBL39486 |
| SCHEMBL39487 |
| SMR000010931 |
| SMR000466277 |
| SMR001233425 |
| SPBio_002901 |
| SR-01000325781 |
| SR-01000325781-1 |
| SR-01000325781-3 |
| SR-01000325781-5 |
| SR-01000597569 |
| SR-01000597569-1 |
| ST2413089 |
| SW197275-2 |
| Tox21_110628 |
| Tox21_110628_1 |
| UNII-Z22628B598 |
| US9394290, ETO (etomidate) |
| VA10867 |
| Z22628B598 |
| Z802671476 |
| ZB000327 |
| ZINC1408 |
| ZINC17364045 |
US Patents and Regulatory Information for etomidate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Emcure Pharms Ltd | ETOMIDATE | etomidate | INJECTABLE;INJECTION | 204618-001 | Aug 13, 2014 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Gland Pharma Ltd | ETOMIDATE | etomidate | INJECTABLE;INJECTION | 209058-001 | Apr 18, 2017 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Mylan Labs Ltd | ETOMIDATE | etomidate | INJECTABLE;INJECTION | 201044-001 | Feb 7, 2017 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2019 - 2020
NCE-1 Patent Challenge Dates 2019 - 2020
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2019 - 2020
NCE-1 Patent Challenge Dates 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.